Individualized treatment, rather than presumed superiority, should shape decisions ...

Aspergillosis is a silent fungal lung infection affecting millions worldwide, often misdiagnosed due to symptoms resembling ...

Noxafil indications have been expanded in Europe to include broader pediatric use, with age-, weight-, and formulation-specific recommendations.

A lingering cough is often blamed on asthma or past tuberculosis, but experts warn that a lesser-known fungal lung disease ...

Kinnear Pharmaceuticals, LLC, a subsidiary of N8 Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation for ...

Aspergillus, a common airborne fungus, is inhaled daily by most people without harm. But for those with weak immunity or lung ...

* TFF PHARMACEUTICALS ANNOUNCES PHASE 1 CLINICAL TRIAL PROGRESS FOR VORICONAZOLE INHALATION POWDER TO TREAT INVASIVE PULMONARY ASPERGILLOSIS Source text for Eikon: Further company coverage: ...

Some researchers are sounding the alarm about a potentially deadly fungus that could spread throughout parts of the US, Europe and Asia. The study article, which was published in pre-print (not yet ...

Genetic mutations are driving an increase in the variation of triazole-resistant genotypes and phenotypes of Aspergillus fumigatus, and most individual infections involved include multiple genotypes, ...